118 related articles for article (PubMed ID: 3305373)
1. Immunological monitoring and early prediction of rejection in renal allograft recipients.
Attallah AM; Abdelghaffar H; Alghraoui F; Fawzy A; Alijani MR; Mahmoud LA; Ghoneim MA; Helfrich GB
Int Arch Allergy Appl Immunol; 1987; 84(1):10-7. PubMed ID: 3305373
[TBL] [Abstract][Full Text] [Related]
2. Early immunological prediction of renal allograft rejection.
Attallah AM; Abdelghaffar H; Fawzy A; Alghraoui F; Alijani MR; Mahmoud LA; Ghoneim MA; Helfrich GB
Int Arch Allergy Appl Immunol; 1987; 83(1):83-7. PubMed ID: 2437058
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immunity and biological response modifiers in insulin-dependent diabetes mellitus complicated by end-stage renal disease.
Attallah AM; Abdelghaffar H; Fawzy A; Alghraoui F; Alijani MR; Mahmoud LA; Ghoneim MA; Helfrich GB
Int Arch Allergy Appl Immunol; 1987; 83(3):278-83. PubMed ID: 3110074
[TBL] [Abstract][Full Text] [Related]
4. Study of antibody dependent cellular cytotoxicity (ADCC). II. ADCC activity in renal graft recipients and acute accelerated graft rejection.
Wasik M; Gradowska L; Lao M; Rowińska D; Orłowski T
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):311-4. PubMed ID: 373680
[TBL] [Abstract][Full Text] [Related]
5. The early posttransplant prognosis of acute renal allograft rejection as determined by detection of cytotoxic antibodies to lymphoid B cell lines.
Lordon RE; Stelzer GT; Ferrone S
Transplantation; 1984 Nov; 38(5):493-7. PubMed ID: 6388071
[TBL] [Abstract][Full Text] [Related]
6. Human renal allograft rejection is predicted by serial determinations of antibody-dependent cellular cytotoxicity.
Dumble LJ; MacDonald IM; Kincaid-Smith P
Transplantation; 1980; 29(1):30-4. PubMed ID: 6989039
[TBL] [Abstract][Full Text] [Related]
7. The effects of donor-specific blood transfusion enhancement of rat renal allografts on cytotoxic activity and phenotypes of peripheral blood lymphocytes, splenocytes, and graft-infiltrating cells.
Wasowska B; Baldwin WM; Howell DN; Sanfilippo F
Transplantation; 1991 Feb; 51(2):451-9. PubMed ID: 1994542
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell activity in the rat. VI. Characterization of rat large granular lymphocytes as effector cells in natural killer and antibody-dependent cellular cytotoxic activities.
Fukui H; Overton WR; Herberman RB; Reynolds CW
J Leukoc Biol; 1987 Feb; 41(2):130-42. PubMed ID: 2433376
[TBL] [Abstract][Full Text] [Related]
9. Renal allograft rejection: protection of renal epithelium from natural killer cells by cytokine-induced up-regulation of class I major histocompatibility antigens.
Lin Y; Proud G; Taylor RM; Kirby JA
Immunology; 1993 Jun; 79(2):290-7. PubMed ID: 8344707
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of antibody-dependent cellular cytotoxicity and lectin-induced cellular cytotoxicity tests for renal graft rejection.
Wasik M; Gradowska L; Rowińska D; Lao M; Orłowski T
Transplantation; 1981 Sep; 32(3):217-21. PubMed ID: 7025371
[TBL] [Abstract][Full Text] [Related]
11. Serum & urinary interleukin-2 levels as predictors in acute renal allograft rejection.
Gupta RK; Jain M; Sharma RK
Indian J Med Res; 2004 Jan; 119(1):24-7. PubMed ID: 14997990
[TBL] [Abstract][Full Text] [Related]
12. Sequential changes in NK and ADCC effector cell function after organ transplantation in man.
Hegarty JH; Ramsden CW; Dowd PS; Giles GR; Guillou PJ
Biomed Pharmacother; 1983; 37(6):266-70. PubMed ID: 6367846
[TBL] [Abstract][Full Text] [Related]
13. Increased CD16 expression on NK cells is indicative of antibody-dependent cell-mediated cytotoxicity in chronic-active antibody-mediated rejection.
Sablik KA; Litjens NHR; Klepper M; Betjes MGH
Transpl Immunol; 2019 Jun; 54():52-58. PubMed ID: 30794946
[TBL] [Abstract][Full Text] [Related]
14. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
15. Specific and nonspecific cytotoxicity of leukocytes from human renal allograft recipients against donor fibroblasts.
Pierce GE; Barth RF; Vessella RL; Cross DE; Stewart CS
Transplantation; 1979 Mar; 27(3):156-62. PubMed ID: 373179
[TBL] [Abstract][Full Text] [Related]
16. Anti-B lymphocytotoxins in renal-allograft rejection.
Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
[TBL] [Abstract][Full Text] [Related]
17. In situ effector pathways of allograft destruction. 1. Generation of the "cellular" effector response in the graft and the graft recipient.
Nemlander A; Soots A; Häyry P
Cell Immunol; 1984 Dec; 89(2):409-19. PubMed ID: 6391690
[TBL] [Abstract][Full Text] [Related]
18. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance.
Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
J Immunol; 2001 May; 166(9):5619-28. PubMed ID: 11313402
[TBL] [Abstract][Full Text] [Related]
19. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients receiving high-dose immunosuppressive therapy.
Lipinski M; Tursz T; Kreis H; Finale Y; Amiel JL
Transplantation; 1980 Mar; 29(3):214-8. PubMed ID: 6987785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
